Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 2/3 1

Status

Recruiting 3Not yet recruiting 2

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

CNS 4Breast 1

Conditions

Brain Neoplasms 4Motor Activity 1Cognitive Dysfunction 1Breast Neoplasms 1

Interventions

Specimen Handling 273Magnetic Resonance Spectroscopy 226pembrolizumab 218Carboplatin 174Biopsy 164Cisplatin 157Nivolumab 155Cyclophosphamide 139Radiotherapy 121Paclitaxel 120Gemcitabine 113durvalumab 90Bevacizumab 89Dexamethasone 82Rituximab 81Oxaliplatin 77venetoclax 73atezolizumab 70Doxorubicin 70Docetaxel 66Radiosurgery 65Fluorouracil 65Ipilimumab 64Capecitabine 64Etoposide 62Radiation 59Prednisone 59Cytarabine 59Lenalidomide 56fludarabine 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Memantine × 90 days × Clear all
NCT06727773 2026-05-06

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
90 enrolled
Breast

Breast Neoplasms, Motor Activity, Cognitive Dysfunction

NCT05045950 2026-05-01

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (PRDR) Technique

Medical College of Wisconsin

Phase 2 Recruiting
53 enrolled
CNS

Brain Neoplasms

NCT05013892 2026-04-16

NTS-WBRT in Brain Metastases

Massachusetts General Hospital

Phase 2 Recruiting
41 enrolled
CNS

Brain Neoplasms

NCT07248228 2026-04-08

Memory Avoidance Whole Brain Radiotherapy vs Hippocampal Avoidance Whole Brain Radiotherapy (Athena 2 Trial)

Case Comprehensive Cancer Center

Phase 2 Not yet recruiting
90 enrolled
CNS

Brain Neoplasms

NCT07470606 2026-03-13

MemoryRT

The University of Texas Health Science Center at San Antonio

Phase 2 Not yet recruiting
108 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡